| Gene or chromosome | Inheritance |
---|---|---|
Hormonal | Â | Â |
 Growth hormone deficiency, or resistance | Genetic or acquired | Variable |
 ACTH deficiency or resistance; cortisol deficiency | Genetic or acquired | Variable |
 Glucagon deficiency* | GCG, DBH | N/D |
 Dopamine beta-hydroxylase deficiency* | GCG, DBH | N/D |
Metabolic | Â | Â |
 Glycogen storage disease (GSD) |  |  |
  GSD 0; glycogen synthase deficiency | GYS2 | AR |
  GSD III; glycogen debranching enzyme deficiency | AGL | AR |
  GSD VI; glycogen phosphorylase deficiency | PYGL | AR |
  GSD IX; phosphorylase kinase subunit deficiencies | PHKA2, PHKB, PHKG2 | X-linked, AR |
 Glucose metabolism and transport |  |  |
  Phosphoglucomutase I deficiency | PMG1 | AR |
  Pyruvate carboxylase deficiency | PC | AR |
 Organic acidemias |  |  |
  Maple syrup urine disease, propionic aciduria, methylmalonic aciduria | Multiple genes | AR |
 Ketone body transport and metabolism |  |  |
  Monocarboxylase transporter 1 defect | SLC16A1 (MCT1) | AR,AD |
  Ketolysis |  |  |
  Succinyl CoA oxoacid transferase deficiency | SCOT | AR |
  Mitochondrial acetoacetyl-CoA thiolase (beta-ketothiolase) deficiency | ACAT1 | AR |
Syndromes | Â | Â |
 Silver–Russel syndrome | 11p15 or 7** | Mostly sporadic |
 Prader–Willi syndrome | 15q11-q13*** | Mostly sporadic |
 Fanconi–Bickel syndrome | SLC2A2 (GLUT2) | AR |
Secondary KH to chronic malnutrition, severe malaria, other chronic diseases | - | - |
Idiopathic ketotic hypoglycemia | Â | Â |
 Physiological KH in prolonged fasting or acute illness | - | - |
 Pathological KH | - | - |
  IGF2BP1 deficiency* | IGF2BP1 | N/D |
  Sodium glucose co-transporter 2 defect* | SLC5A2 | N/D |
  PEP carboxykinase 1 and G-6P catalytic transcriptional induction* | NCOR1 | N/D |
  Mitosis gene A-related kinase 11 defect* | NEK11 | N/D |